title: Subdominant Gag-specific anti-HIV efficacy in an HLA-B*57-positive elite controller.
authors.affiliation: aDepartment of Paediatrics bNuffield Department of Medicine, University of Oxford, Oxford cGloucestershire Royal Hospital, Gloucester, UK dInstitute for HIV Research, University Hospital Essen, University Duisburg-Essen, Essen, Germany eHIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa fDepartment of Infectious Diseases and Microbiology, Oxford University Hospitals NGS Trust, John Radcliffe Hospital, Oxford, UK.
authors.forename: Ellen M
authors.initials: EM
authors.lastname: Leitman
authors.forename: Christian B
authors.initials: CB
authors.lastname: Willberg
authors.forename: Andrew
authors.initials: A
authors.lastname: De Burgh-Thomas
authors.forename: Hendrik
authors.initials: H
authors.lastname: Streeck
authors.forename: Philip J R
authors.initials: PJ
authors.lastname: Goulder
authors.forename: Philippa C
authors.initials: PC
authors.lastname: Matthews
mesh_terms: D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D015488:HIV Antigens / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology*; D020276:HIV Long-Term Survivors; D015235:HLA-B Antigens / Q000378:metabolism*; D006801:Humans; D008875:Middle Aged; D054301:gag Gene Products, Human Immunodeficiency Virus / Q000276:immunology*
chemical_list: D015488:HIV Antigens; D015235:HLA-B Antigens; C103707:HLA-B57 antigen; D054301:gag Gene Products, Human Immunodeficiency Virus